Search results for "Statins"
Intensive statin therapy after stroke associated with higher risk of hemorrhage
No difference was found in risk of stroke recurrence between moderate- and high-intensity statin therapy, but the latter resulted in a higher risk for intracranial hemorrhage, a Chinese study found.
https://immattersacp.org/weekly/archives/2024/07/16/2.htm
16 Jul 2024
Breaking barriers in PAD treatment
Medical societies released an updated guideline for the management of lower-extremity peripheral artery disease (PAD) that includes preventive medical therapy and the latest thinking on effective screening, diagnosis, treatment, and risk management strategies.
https://immattersacp.org/archives/2024/10/breaking-barriers-in-pad-treatment.htm
1 Oct 2024
Statins not commonly used among younger cohorts even after ASCVD diagnosis
Among patients ages 18 to 44 years diagnosed with atherosclerotic cardiovascular disease (ASCVD), statin use changed from 18.34% in 1999 to 16.63% in 2020, according to data from the National Health and Nutrition Examination Survey.
https://immattersacp.org/weekly/archives/2024/08/20/4.htm
20 Aug 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2024
Statins safe, offer benefits even in very old patients
Reductions in cardiovascular disease (CVD) after statin therapy were seen in patients up to ages 85 years or older without increasing risks for severe adverse effects.
https://immattersacp.org/weekly/archives/2024/05/28/1.htm
28 May 2024
Recommendations released on statin therapy for people with HIV
The guidance from a panel of the U.S. Department of Health and Human Services addresses primary prevention of atherosclerotic cardiovascular disease in patients ages 40 to 75 years and younger than age 40 years.
https://immattersacp.org/weekly/archives/2024/03/05/2.htm
5 Mar 2024
The never-ending push-pull of statins
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017
U.S. statin use plateaued in 2013 to 2018
Most U.S. adults with the strongest guideline recommendations for primary prevention with statins are not receiving them, including those with diabetes, extremely high cholesterol levels, or 10-year risk of cardiovascular disease over 20%, a study found.
https://immattersacp.org/weekly/archives/2023/12/05/1.htm
5 Dec 2023
Tips for using statins, PCSK9 inhibitors in chronic CAD
Guidelines for reducing cardiovascular risk are shifting with the evidence.
https://immattersacp.org/archives/2017/06/statin.htm
1 Jun 2017
Statins underused in patients with cardiovascular disease, study finds
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
https://immattersacp.org/weekly/archives/2023/08/08/2.htm
8 Aug 2023